Pages that link to "Q28368101"

The following pages link to Demonstration of an in vivo functional beta 3-adrenoceptor in man (Q28368101):

Displaying 46 items.

• Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function (Q24561366) (← links)
• Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer (Q24800485) (← links)
• Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus (Q28315009) (← links)
• Cholinoceptor‐mediated effects on glycerol output from human adipose tissue using in situ microdialysis (Q28367796) (← links)
• Genomic cloning and species-specific properties of the recombinant canine beta3-adrenoceptor. (Q31937599) (← links)
• Combination of a Beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity (Q33598749) (← links)
• Adrenoceptor genes in human obesity (Q33680509) (← links)
• Microdialysis in peripheral tissues (Q34100158) (← links)
• Microdialysis in clinical drug delivery studies (Q34100178) (← links)
• The Gln27Glu Polymorphism in β2-Adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis (Q34133844) (← links)
• Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome (Q34235779) (← links)
• Adrenergic control of lipolysis in women compared with men. (Q34440153) (← links)
• Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue (Q35027912) (← links)
• Emerging paradigms for understanding fatness and diabetes risk (Q35087572) (← links)
• In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue (Q35873433) (← links)
• Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues (Q35873569) (← links)
• Metabolism of lipids in human white adipocyte (Q35938856) (← links)
• Arginine 16 Glycine Polymorphism in β2-Adrenergic Receptor Gene is Associated with Obesity, Hyperlipidemia, Hyperleptinemia, and Insulin Resistance in Saudis (Q36296561) (← links)
• Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects (Q36323717) (← links)
• Applicability of reverse microdialysis in pharmacological and toxicological studies (Q36433024) (← links)
• Gene-gene, gene-environment & multiple interactions in colorectal cancer (Q36475800) (← links)
• Dietary trace amine-dependent vasoconstriction in porcine coronary artery (Q36964909) (← links)
• Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist (Q37356667) (← links)
• The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts (Q37361164) (← links)
• A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys (Q37382503) (← links)
• Obesity-related gene ADRB2, ADRB3 and GHRL polymorphisms and the response to a weight loss diet intervention in adult women. (Q37644406) (← links)
• Function and regulation of the beta 3-adrenoceptor (Q41287913) (← links)
• Adrenergic control of post-exercise metabolism (Q41760194) (← links)
• Down-regulation of beta3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition: evidence for a role of insulin (Q42801593) (← links)
• The Arg16Gly polymorphism of human beta2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people (Q43742365) (← links)
• Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver (Q43805976) (← links)
• Effects of insulin on adipose tissue blood flow in man. (Q43977835) (← links)
• Local metabolic changes in subcutaneous adipose tissue during intravenous and epidural analgesia (Q44004368) (← links)
• Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans (Q44104217) (← links)
• Beta3-adrenoceptor function and long-term changes in body weight (Q47188169) (← links)
• Comparative genome analysis with the human genome reveals chicken genes associated with fatness and body weight (Q47347043) (← links)
• Association of adrenergic receptor gene polymorphisms with adolescent obesity in Taiwan. (Q51384225) (← links)
• Leptin: a review of its peripheral actions and interactions (Q56169405) (← links)
• Lipolytic and nutritive blood flow response to beta-adrenoceptor stimulation in situ in subcutaneous abdominal adipose tissue in obese men (Q72999980) (← links)
• Elevated serum leptin in patients with coronary artery disease: no association with the Trp64Arg polymorphism of the beta3-adrenergic receptor (Q73658785) (← links)
• Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity (Q73775741) (← links)
• Structure and function of the beta 3 adrenoreceptor (Q73780949) (← links)
• Microdialysis for the assessment of catecholamine-induced lipolysis in adipose and skeletal muscle tissue (Q73781055) (← links)
• Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling (Q74460505) (← links)
• Monitoring adipose tissue blood flow in man: a comparison between the (133)xenon washout method and microdialysis (Q77488325) (← links)
• Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients (Q78025141) (← links)